On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Star Technology and Research (United States)

InstitutionResearch output, impact & collaborations

Star Technology and Research (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Star Technology and Research (United States)?

ScholarIQrecord summary

Star Technology and Research (United States) is a research organisation in Mt. Pleasant, US. OpenAlex records 1,737 works and 38,645 citations for it. 1,071 researchers list it as their most recent affiliation.

How many works does Star Technology and Research (United States) have?

ScholarIQindexed works

Star Technology and Research (United States) has 1,737 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Star Technology and Research (United States) have?

ScholarIQcitation count

Star Technology and Research (United States) has 38,645 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Star Technology and Research (United States)?

ScholarIQresearcher count

Star Technology and Research (United States) has 1,071 researchers in the ScholarIQ index.

What is the average h-index at Star Technology and Research (United States)?

ScholarIQavg h-index

Star Technology and Research (United States) has an average h-index of 56.3 in OpenAlex.

What is the ROR of Star Technology and Research (United States)?

ScholarIQror

The ROR for Star Technology and Research (United States) is on the source record.

What is the OpenAlex record for Star Technology and Research (United States)?

ScholarIQopenalex

The OpenAlex for Star Technology and Research (United States) is on the source record.

Who are the most-cited researchers behind Star Technology and Research (United States)?

ScholarIQtop researchers by citations
1
Neal D. Shore · Prostate Cancer Treatment and Research
1,308 works47,064 citations
2
Emiliano Calvo · Cancer Immunotherapy and Biomarkers
693 works16,761 citations
3
Yves Cohen · Respiratory Support and Mechanisms
538 works16,520 citations
4
Martin Bunke · Renal Transplantation Outcomes and Treatments
50 works711 citations

What are the most-cited papers on Star Technology and Research (United States)?

ScholarIQmost cited works
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher, Karim Fizazi, Fred Saad, Mary‐Ellen Taplin, Cora N. Sternberg, Kurt Miller, Ronald de Wit, Peter F.A. Mulders, Kim N., Neal D. Shore, Andrew J. Armstrong, Thomas W. Flaig, Aude Fléchon, Paul N. Mainwaring, Mark T. Fleming, John D. Hainsworth, Mohammad Hirmand, Bryan Selby, Lynn Seely, Johann S. de Bono
New England Journal of Medicine. 20124,604 CitationsOPEN ACCESS
Olaparib for Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono, Joaquı́n Mateo, Karim Fizazi, Fred Saad, Neal D. Shore, Shahneen Sandhu, Kim N., Oliver Sartor, Neeraj Agarwal, David Olmos, Antoine Thiery-Vuillemin, Przemyslaw Twardowski, Niven Mehra, Carsten Goessl, Jinyu Kang, Joseph E. Burgents, Wenting Wu, Alexander Kohlmann, Carrie A. Adelman, Maha Hussain
New England Journal of Medicine. 20202,278 CitationsOPEN ACCESS
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
Karim Fizazi, Michael A. Carducci, Matthew R. Smith, Ronaldo Damião, Janet E. Brown, Lawrence I. Karsh, Piotr Milecki, Neal D. Shore, Michael Rader, Huei Wang, Qi Jiang, Sylvia Tadros, Roger Dansey, Carsten Goessl
The Lancet. 20111,972 CitationsOPEN ACCESS
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer
Maha Hussain, Joaquı́n Mateo, Karim Fizazi, Fred Saad, Neal D. Shore, Shahneen Sandhu, Kim N., Oliver Sartor, Neeraj Agarwal, David Olmos, Antoine Thiery-Vuillemin, Przemyslaw Twardowski, Guilhem Roubaud, Mustafa Özgüroğlu, Jinyu Kang, Joseph E. Burgents, Christopher Gresty, Claire Corcoran, Carrie A. Adelman, Johann S. de Bono
New England Journal of Medicine. 2020778 CitationsOPEN ACCESS
Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial
Neeraj Agarwal, Arun Azad, Joan Carles, André P. Fay, Nobuaki Matsubara, Daniel Heinrich, Cezary Szczylik, Ugo De Giorgi, Jae Young Joung, Peter C.C. Fong, Éric Voog, Robert J. Jones, Neal D. Shore, Curtis Dunshee, Stefanie Zschäbitz, Jan Oldenburg, Xun Lin, Cynthia G. Healy, Nicola Di Santo, Fabian Zohren, Karim Fizazi
The Lancet. 2023518 Citations

How much of the research on Star Technology and Research (United States) is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
17%
Hybrid
8%
Bronze
42%
Closed
33%

Related on ScholarIQ

470M+ articles · 14-day free trial